Vous êtes sur la page 1sur 9

DAFTAR PUSTAKA

Acharya, S. K., Sreenivas, V., Gupta, S. D., Kumar, S., Chawla, Y. K., Tandon,
A., et al., 2012. Treatment of Chronic Hepatitis due to Hepatitis C Virus
(CH-C) in India: A Randomized Controlled Trial Comparing Daily
Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and
GlycyrrhizinA Multicenter Study. J. Clin. Exp. Hepatol., 2(1), 1018
Alternatif Medicine Review (AMR), 2005, Monograph : Glycyrrhiza glabra,
Thome Research, AMR Vol 10 (3) : 230-237. Diakses pada tanggal 5
Oktober 2012 di www.thome.com
Amirudin R., 2009, Fisiologi dan Biokimia Hati dalam editor Sudoyo A.w.,
Setiyohadi B., Alwi I., Setiati S. dan Simadibrata K.M, Buku Ajar Ilmu
Penyakit Dalam Jilid I Edisi V, Jakarta : Internal Publishing, 98 : 627-633.
Anonim, 2001, Glycine, In: Hendler SS, et al, editors, PDR for nutritional
supplements, Montvale: Medical Economics Company, Inc. p.197-9, 25961.
Arase, Y., Ikeda, K., Murashima, N., Chayama, K., Tsubota, A., Koida, I., et al.,
1997.The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Cancer, 79(8), 14941500.
Asl, M. N., dan Hosseinzadeh, H., 2008. Review of Pharmacological Effects of
Glycyrrhiza sp. and its Bioactive Compounds. Phytother. Res., 22(6), 709
724, diakses pada tanggal 10 Oktober 2012 di www.interscince.wiley.com

61

Barnes, J., Anderson, L.A., dan Phillipson, J.D., 2005, Herbal Medicines 2nd, The
American Herb Association : Pharmaceutical Press.
Blanco Vela, C. I., dan Poo Ramrez, J. L., 2011. Efficacy of oral L-ornithine Laspartate

in

cirrhotic

patients

with

hyperammonemic

hepatic

encephalopathy. Ann. Hepatol., 10 Suppl 2, S5559.


Cao, Z., Zhao, Z., dan Zhao, X., 2006. Effect of compound glycyrrhizin injection
on liver function and cellular immunity of children with infectious
mononucleosis complicated liver impairment. Chin. J. Integr. Med., 12,
268272.
Coon, J. T., dan Ernst, E., 2004. Complementary and alternative therapies in the
treatment of chronic hepatitis C: a systematic review. J. Hepatol., 40(3),
491500.
Das, S. K., Gupta, G., Rao, D. N., dan Vasudevan, D. M., 2007. Effect of lecithin
with vitamin-B complex and tocopheryl acetate on long term effect of
ethanol induced immunomodulatory activities. Indian J. Exp. Biol., 45(8),
683.
Departemen Kesehatan RI, 2007, Pharmaceutical Care untuk Penyakit Hati,
Direktorat Bina Farmasi Komunitas dan Klinik, 1-29.
Feng, Y., Cheung, K.-F., Wang, N., Liu, P., Nagamatsu, T., dan Tong, Y., 2009.
Chinese medicines as a resource for liver fibrosis treatment. Chin. Med., 4,
16,

diakses

pada

tanggal

19

Oktober

2012

di

http://www.cmjournal.org/content/4/1/16

62

Hikino H, Kiso Y. Natural products for liver diseases. In: Wagner H, Hikino H,
Farnsworth N R, eds., 1988, Economic and Medicinal Plant Research,.
New York: Academic Press, vol 2 :49.
Iino, S., Tango, T., Matsushima, T., Toda, G., Miyake, K., Hino, K., et al., 2001.
Therapeutic effects of stronger neo-minophagen C at different doses on
chronic hepatitis and liver cirrhosis.Hepatol. Res., 19(1), 3140.
Ikeda, K., Arase, Y., Kobayashi, M., Saitoh, S., Someya, T., Hosaka, T., et al.,
2006. A long-term glycyrrhizin injection therapy reduces hepatocellular
carcinogenesis rate in patients with interferon-resistant active chronic
hepatitis C: a cohort study of 1249 patients. Dig. Dis. Sci., 51(3), 603609.
Karino A, et al., 2004, Stronger Neo-Minophagen C (SNMC) for the treatment of
chronic hepatitis C. The Cell;36(8):37-43
Kenward R. dan Tan C.K., 2002, Penggunaan Obat pada Gangguan Hati dalam
editor : Aslam M., Tan C.K., dan Prayitno A., Farmasi Klinis, Surabaya,
Alex Media Komputindo, 10 : 155-174.
Kim, S.-W., Ha, K.-C., Choi, E.-K., Jung, S.-Y., Kim, M.-G., Kwon, D.-Y., et al.,
2013. The effectiveness of fermented turmeric powder in subjects with
elevated alanine transaminase levels: a randomised controlled study. BMC
Complement. Altern. Med., 13(1), 58.
Koda-Kimble, M.A., Young, L.Y., Alldredge, B.K., Corelli, R.L., Guglielmo,
B.J., Kradjan, W.A., Williams, B.R., 2009. Apllied Therapeutics The
Clinical Use of Drugs, 9th Edition, Lippincott Williams and Wilkins.

63

Kumada, H., 2002. Long-term treatment of chronic hepatitis C with glycyrrhizin


[stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and
hepatocellular carcinoma. Oncology, 62 Suppl 1, 94100.
Kumada, H., Okanoue, T., Onji, M., Moriwaki, H., Izumi, N., Tanaka, E., et al.,
2010. Guidelines for the treatment of chronic hepatitis and cirrhosis due to
hepatitis B virus infection for the fiscal year 2008 in Japan. Hepatol. Res.,
40(1), 17.
Lelosutan, S.A.R., 2006, Pengalaman dengan Glizyrrhizin Injeksi, Dexa Media,
No. 2, Vol. 19, April-Juni 2006 : 59-65.
Lin C.C., dan Wang P.H., 2012, Intravenous Glycyrrhizin Improved Serum
Transaminase Rapidly in a Chronic Hepatitis B patient with Acute
Exacerbation,Elsevier Taiwan LLC & Formosan Medical Association.
Diakses pada tanggal 15 Oktober 2012 di http://dx.doi.org/10.1016/j.jfma.
Mitsuyoshi, H., Nakashima, T., Inaba, K., Ishikawa, H., Sakamoto, Y.,
Matsumoto, N., et al., 1996. Ursodeoxycholic acid decreases the serum
transaminase levels of chronic liver disease patients treated with
glycyrrhizin. Int. Hepatol. Commun.,6(2), 8591.
Miyake, K., Tango, T., Ota, Y., Mitamura, K., Yoshiba, M., Kako, M., et al.,
2002. Efficacy of Stronger Neo-Minophagen C compared between two
doses administered three times a week on patients with chronic viral
hepatitis. J. Gastroenterol. Hepatol.,17(11), 11981204.

64

Okuno, T., Arai, K., dan Shindo, M., 1994. (Efficacy of interferon combined
glycyrrhizin therapy in patients with chronic hepatitis C resistant to
interferon therapy). Nihon Rinsho Jpn. J. Clin. Med., 52(7), 18231827.
Omata, M., Kanda, T., Yu, M.-L., Yokosuka, O., Lim, S.-G., Jafri, W., et al,
2012. Guidelines : Asian Pacific Association for the Study of the Liver
(APASL) consensus statements and management algorithms for hepatitis
C virus infection, Hepatol Int, DOI 10.1007/s12072-012-9342-y
Orlent, H., Hansen, B. E., Willems, M., Brouwer, J. T., Huber, R., Kullak-Ublick,
G. A., et al., 2006. Biochemical and histological effects of 26 weeks of
glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial.
J. Hepatol., 45(4), 539546, diakses pada tanggal 10 Oktober 2012 di
www.elsevier.com/locate/jhep
Pridady, F.X., 2009, Kolesistitis dalam editor Sudoyo A.w., Setiyohadi B., Alwi
I., Setiati S. dan Simadibrata K.M, Buku Ajar Ilmu Penyakit Dalam Jilid I
Edisi V, Jakarta : Internal Publishing, 98 : 718-720.
Rossum, T. G. J. V., Vulto, Man, R. A. D., Brouwer, dan Schalm., 1998.
glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment.
Pharmacol.Ther.,12(3), 199205.
Rossum, T.G.J.V., Vulto, A.G., Hop, W.C., Brouwer, B.T., Niesters, H.G., dan
Schalm, S.W., 1999a. Intravenous Glycyrrhizin For The Treatmen Of
Chronic Hepatitis C A Double-Blind, Randomized, Placebo-Controlled
Phase I/II Trial, J. Gastroentrology and Hepatology 14, p : 1093-1099.

65

Rossum, T. G. J. V, Vulto, A. G., Hop, W. C. J., dan Schalm, S. W., 1999b.


Pharmacokinetics of intravenous glycyrrhizin after single and multiple
doses in patients with chronic hepatitis C infection. Clin. Ther., 21(12),
20802090.
Rossum, T. G. V., De Jong, F. H., Hop, W. C., Boomsma, F., dan Schalm, S. W.,
2001. Pseudo-aldosteronism induced by intravenous glycyrrhizin
treatment of chronic hepatitis C patients. J. Gastroenterol. Hepatol.,16(7),
789795.
Shimoyama, Y., Sakamoto, R., Akaboshi, T., Tanaka, M., dan Ohtsuki, K., 2001,
Characterization of Secretory Type IIA Phospholipase A2 (sPLA2-IIA) as
a Glycyrrhizin (GL)-Binding Protein and the GL-Induced Inhibition of the
CK-II-Mediated Stimulation of sPLA2-IIA Activity in Vitro, Biol. Pharm.
Bull. 24(9) 10041008.
Saxena Sanjai, 2005, Glycyrrhiza glabra : Medicine Over The Millenniunm,
Natural Product Radiance Vol 4 (5) September-Oktober 2005.
Schemmer P et al., 1999, Intravenous Glycine Inproves Survivel In Rat Liver
Transplantation. The American Physiological Society:G924-32.
Strader, D.B., dan Zimmerman, H.J., 2000, Complementary and Alternative
Medicine in Hepatitis C, Academic Press : 428-451.
Sumiyama, K., Kobayashi, M., Miyashiro, E., dan Koike, M., 1991. Combination
therapy with transfer factor and high dose stronger neo-minophagen C in chronic
hepatitis B in children (HBe Ag positive). Acta Paediatr. Jpn. Overseas Ed.,
33(3), 327334.

66

Sun, Q.-F., Ding, J.-G., Wang, X.-F., Fu, R.-Q., Yang, J.-X., Hong, L., et al.,
2010. Efficacy and safety of intravenous stronger neo-minophagen C and Sadenosyl-L-methionine in treatment of pregnant woman with chronic hepatitis B:
a pilot study. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res., 16(8), PR914.
Suzuki H, Ohta Y, Takino T, Fujisawa K, Hirayama C, 1983, Effects of
glycyrrhizin on biochemical tests in patients with chronic hepatitis. Asian
Med. J.26: 42338.
Tanaka, N., Yamamura, Y., Santa, T., Kotaki, H., Uchino, K., Sawada,
Y., Aikawa T ; Osuga T ; Iga T, 1993, Pharmacokinetic profiles of
glycyrrhizin in patients with chronic hepatitis. Biopharm. Drug Dispos.,
14(7), 609614.
Tarao, K., Rino, Y., Ohkawa, S., Shimizu, A., Tamai, S., Miyakawa, K., et al.,
1999. Association between high serum alanine aminotransferase levels and
more rapid development and higher rate of incidence of hepatocellular
carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer,
86(4), 589595.
Vajro, P., Mandato, C., Franzese, A., Ciccimarra, E., Lucariello, S., Savoia, M., et
al., 2004. Vitamin E treatment in pediatric obesity-related liver disease: a
randomized study. J. Pediatr. Gastroenterol. Nutr., 38(1), 4855.
Verma, S., dan Thuluvath, P. J., 2007. Complementary and Alternative Medicine
in Hepatology: Review of the Evidence of Efficacy. Clin. Gastroenterol.
Hepatol., 5(4), 408416.

67

Vispute S., dan Khopade A., 2011, Glycyrrhiza glabra Linn Klitaka : a Review,
International Journal of Pharma and Bio Scinces, Vol 2 (3) : 42-49 diakses
pada 10 Oktober 2012 di www.ijpbs.net
Wang R., Kong J., Wang D., Liean L.L., dan Lien E.J., 2007, A Survey of Chinese
Herbal Ingredients With Liver Protection Activities, Chinese Medicine 2 :
5,

diakses

pada

tanggal

10

Oktober

2012

di

www.cmjournal.org/content/2/1/5
Wang, Z. Y., dan Nixon, D. W., 2001. Licorice and Cancer. Nutr. Cancer, 39(1),
111.
Werbach M R, Murray M T., 1994, Botanical influences on illness. Tarzana, CA:
Third Line Press:178-179.
Williamson E, Driver S, dan Baxter K, 2009, StockleysHerbal Medicines
Interactions, London : RPS publishing, L: 272-276.
World Health Organozation (WHO), 1979. ART Adverse Drug Reaction
Terminology,

WHO

collaborating

Center

for

Drug

International

Monitoring : Geneva.
Yang, J.-M., Xian, Y.-F., Ip, P. S. P., Wu, J. C. Y., Lao, L., Fong, H. H. S., dkk.,
2012. Schisandra chinensis reverses visceral hypersensitivity in a
neonatalmaternal separated rat model. Phytomedicine, 19(5), 402408.
Zhang, L., dan Wang, B., 2002. Randomized clinical trial with two doses (100 and
40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic
hepatitis B. Hepatol. Res., 24(3), 220227.

68

Zhang, Y., Ikejima, K., Honda, H., Kitamura, T., Takei, Y., dan Sato, N., 2000.
Glycine prevents apoptosis of rat sinusoidal endothelial cells caused by
deprivation of vascular endothelial growth factor. Hepatology, 32(3), 542
546.

69